Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FRCNR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,826
Award facts
- Contract value 100% obligated
- $19,826.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,826.08 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 15, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the DLA, specifically its $999.999 billion IDC (valued through December 2026) that enables the company to supply a wide range of medications and medical commodities to support military healthcare programs globally. Cosentyx, a biologic immunosuppressant used primarily for autoimmune conditions, reflects the breadth of specialty pharmaceuticals AmerisourceBergen provides to federal military and veteran healthcare systems. As a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, AmerisourceBergen regularly fulfills competitively awarded delivery orders across multiple therapeutic domains through its established relationship with the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FRCNR?
SPE2DB25FRCNR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FRCNR worth?
The government has obligated $19,826 on SPE2DB25FRCNR.
Is contract SPE2DB25FRCNR an order under another contract?
Yes. SPE2DB25FRCNR is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRCNR competed?
The extent of competition for SPE2DB25FRCNR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award